Merck Sues Apotex Over Eye Treatments

Law360, New York (December 5, 2006, 12:00 AM EST) -- Taking on a familiar rival, pharmaceutical giant Merck & Co. Inc. has shot off a pair of suits against Canadian generic drug manufacturer Apotex Inc. to block it from selling generic versions of Merck’s glaucoma treatments.

Merck’s lawsuits, both filed Monday in the U.S. District Court for the District of New Jersey, stemmed from moves by Apotex to gain approval from the U.S. Food and Drug Administration for selling generic copycats of Trusopt and Cosopt, treatments for ocular hypertension that are both covered by one of...
To view the full article, register now.